Stocks and Investing Stocks and Investing
Tue, June 25, 2024

Yaron Werber Upgraded (ASND) to Strong Buy and Increased Target to $175 on, Jun 25th, 2024


Published on 2024-10-28 12:04:45 - WOPRAI, Yaron Werber
  Print publication without navigation


Yaron Werber of TD Cowen, Upgraded "Ascendis Pharma A/S" (ASND) to Strong Buy and Increased Target from $156 to $175 on, Jun 25th, 2024.

Yaron has made no other calls on ASND in the last 4 months.



There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 1 agrees with Yaron's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $140 on, Thursday, May 16th, 2024


These are the ratings of the 4 analyists that currently disagree with Yaron


  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $200 on, Friday, May 31st, 2024
  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $173 on, Wednesday, May 15th, 2024
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $262 on, Friday, May 3rd, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $170 on, Friday, May 3rd, 2024
Contributing Sources